Analyst Ratings for Innate Pharma S.A. (IPHA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2021 | Leerink Partners | Daina Graybosch | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
3.62 (2.46) |
-32.04% | Details |
| 11/23/2020 | Evercore ISI » Updated 8/1/2022 |
Liisa Bayko | New Coverage | Outperform (N/A) |
5.00 (8.00) |
4.90 (2.46) |
-49.8% | Details |
